NZ248285A - Hydrochloride salt of a triazolylthiomethylthio cephem derivative and medicaments - Google Patents

Hydrochloride salt of a triazolylthiomethylthio cephem derivative and medicaments

Info

Publication number
NZ248285A
NZ248285A NZ24828593A NZ24828593A NZ248285A NZ 248285 A NZ248285 A NZ 248285A NZ 24828593 A NZ24828593 A NZ 24828593A NZ 24828593 A NZ24828593 A NZ 24828593A NZ 248285 A NZ248285 A NZ 248285A
Authority
NZ
New Zealand
Prior art keywords
hydrochloride
crystalline hydrate
crystalline
water
hydrate
Prior art date
Application number
NZ24828593A
Other languages
English (en)
Inventor
Hisanori Takahashi
Yutaki Ide
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NZ248285A publication Critical patent/NZ248285A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ24828593A 1992-07-31 1993-07-29 Hydrochloride salt of a triazolylthiomethylthio cephem derivative and medicaments NZ248285A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20496592 1992-07-31

Publications (1)

Publication Number Publication Date
NZ248285A true NZ248285A (en) 1994-07-26

Family

ID=16499234

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ24828593A NZ248285A (en) 1992-07-31 1993-07-29 Hydrochloride salt of a triazolylthiomethylthio cephem derivative and medicaments

Country Status (23)

Country Link
US (1) US5407929A (online.php)
EP (1) EP0581552B1 (online.php)
KR (1) KR100245938B1 (online.php)
CN (1) CN1037683C (online.php)
AT (1) ATE165360T1 (online.php)
AU (1) AU657866B2 (online.php)
BR (1) BR9303235A (online.php)
CA (1) CA2101502A1 (online.php)
DE (1) DE69318077T2 (online.php)
ES (1) ES2115725T3 (online.php)
FI (1) FI933391L (online.php)
GR (1) GR3026699T3 (online.php)
HU (1) HU219637B (online.php)
IL (1) IL106516A (online.php)
MX (1) MX9304611A (online.php)
NO (1) NO303734B1 (online.php)
NZ (1) NZ248285A (online.php)
PH (1) PH30109A (online.php)
PL (2) PL172835B1 (online.php)
RU (1) RU2118959C1 (online.php)
TW (1) TW307769B (online.php)
UA (1) UA37181C2 (online.php)
ZA (1) ZA935529B (online.php)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE05643B1 (et) * 2001-02-24 2013-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina
AT413282B (de) * 2002-02-01 2006-01-15 Sandoz Ag Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
KR20030076759A (ko) * 2002-03-21 2003-09-29 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조 방법
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US6727277B1 (en) 2002-11-12 2004-04-27 Kansas State University Research Foundation Compounds affecting cholesterol absorption
CN101219992B (zh) 2003-02-12 2011-08-31 日产化学工业株式会社 匹伐他汀钙的晶形
JP5230934B2 (ja) 2003-03-27 2013-07-10 バジリア ファルマスーチカ アーゲー 結晶形態のセファロスポリン
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
CN102838599A (zh) 2006-05-04 2012-12-26 贝林格尔.英格海姆国际有限公司 多晶型
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
AU2008290582B2 (en) * 2007-08-17 2014-08-14 Boehringer Ingelheim International Gmbh Purin derivatives for use in the treatment of fab-related diseases
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
MX370599B (es) * 2008-08-15 2019-12-18 Boehringer Ingelheim Int Derivados de purina para su uso en el tratamiento de enfermedades relacionadas con fab.
BRPI0919288A2 (pt) 2008-09-10 2015-12-15 Boehring Ingelheim Internat Gmbh teriapia de combinação para tratamento de diabetes e condições relacionadas.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EA022310B1 (ru) 2008-12-23 2015-12-30 Бёрингер Ингельхайм Интернациональ Гмбх Солевые формы органического соединения
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
NZ599298A (en) 2009-11-27 2014-11-28 Boehringer Ingelheim Int Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
WO2011138421A1 (en) 2010-05-05 2011-11-10 Boehringer Ingelheim International Gmbh Combination therapy
NZ603319A (en) 2010-06-24 2015-04-24 Boehringer Ingelheim Int Diabetes therapy
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
CA2841552C (en) 2011-07-15 2020-06-23 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303554A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in sirs and/or sepsis
EP3685839A1 (en) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin for use in the treatment of albuminuria and kidney related diseases
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
WO2017211979A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES475573A1 (es) * 1977-07-12 1980-01-16 Fujisawa Pharmaceutical Co Un procedimiento para preparar nuevos compuestos de cefem
IE65926B1 (en) * 1990-07-19 1995-11-29 Shionogi & Co Thioalkylthio cephalosporin derivatives

Also Published As

Publication number Publication date
PH30109A (en) 1996-12-27
HUT68602A (en) 1995-06-28
MX9304611A (es) 1994-02-28
CN1037683C (zh) 1998-03-11
UA37181C2 (uk) 2001-05-15
IL106516A0 (en) 1993-11-15
GR3026699T3 (en) 1998-07-31
FI933391A0 (fi) 1993-07-29
NO303734B1 (no) 1998-08-24
AU4422793A (en) 1994-02-03
ATE165360T1 (de) 1998-05-15
HU9302194D0 (en) 1993-10-28
TW307769B (online.php) 1997-06-11
FI933391A7 (fi) 1994-02-01
AU657866B2 (en) 1995-03-23
ES2115725T3 (es) 1998-07-01
IL106516A (en) 1998-06-15
EP0581552A3 (en) 1994-06-01
BR9303235A (pt) 1994-03-01
ZA935529B (en) 1994-02-24
NO932745D0 (no) 1993-07-30
DE69318077T2 (de) 1998-10-29
RU2118959C1 (ru) 1998-09-20
EP0581552B1 (en) 1998-04-22
FI933391L (fi) 1994-02-01
CA2101502A1 (en) 1994-02-01
US5407929A (en) 1995-04-18
PL172830B1 (pl) 1997-12-31
KR940005636A (ko) 1994-03-22
NO932745L (no) 1994-02-01
CN1089948A (zh) 1994-07-27
PL172835B1 (pl) 1997-12-31
DE69318077D1 (de) 1998-05-28
KR100245938B1 (ko) 2000-04-01
EP0581552A2 (en) 1994-02-02
PL299870A1 (en) 1994-02-07
HU219637B (hu) 2001-06-28

Similar Documents

Publication Publication Date Title
EP0581552B1 (en) Triazolylthiomethylthio cephalosporin hyrochloride, its crystalline hydrate and the production of the same
JPH0128036B2 (online.php)
US20050245738A1 (en) Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
JP2007023046A (ja) 抗細菌セファロスポリン類
WO2007096740A2 (en) Novel cephalosporins
JPH0245634B2 (online.php)
WO2007010555A2 (en) Novel crystalline forms of moxifloxacin hydrochloride and process for preparation thereof
US4189479A (en) Cephalosporin esters
EP0547646B1 (en) Crystalline form of a cephalosporin antibiotic
JPH0741484A (ja) セフェム化合物及び抗菌剤
JPS6232194B2 (online.php)
JP2575590B2 (ja) トリアゾリルチオメチルチオセファロスポリン塩酸塩およびその水和物結晶ならびにそれらの製法
KR100696422B1 (ko) 항생물질로서 사이클릭 아미노구아니딘 치환체를 가진세팔로스포린
EP0439353B1 (en) Crystalline hydrochloride of new beta-lactam antibiotic and process therefor
US8431562B2 (en) Crystalline sodium salt of cephalosporin antibiotic
US20080221076A1 (en) Crystalline Sodium Salt of Cephalosporin Antibiotic
CN1315846C (zh) 7 －{ [ ( 5 －氨基 － 1 , 2 , 4 －噻二唑 － 3 －基 ) (氟代甲氧基亚氨基 )乙酰基 ]氨基} － 3 － [ (亚氨基 － 1－哌嗪基甲基 ) －甲基亚肼基 ] －甲基 －3 －头孢烯 － 4 －羧酸的结晶盐酸化物
JP2649101B2 (ja) イソセフェム誘導体およびその製造方法
IE47929B1 (en) Substituted imidazolidinyl-3-chloro-3-cephem-4-carboxylic acids
GB2091263A (en) 7-((carboxy-methoximino)-lh-pyrazol-3-yl-acetyl))-amino-3-desacetoxy-3-(l-methyl-lh-tetrazol-5-yl-thio)cepha 10-sporanic acid
GB2086375A (en) Thiazolidine derivatives with antibiotic activity
JPS5978189A (ja) ピロロ〔３，２，１−ｉｊ〕キノリン−５−カルボン酸誘導体
JP2010013356A (ja) 結晶性カルバペネム化合物
JPH0278684A (ja) ２−オキサ−イソセフェム誘導体
SI8510745A8 (sl) Postopek za pripravo soli-hidratov derivatov cefalosporina